TCRX TScan Therapeutics, Inc. - Common Stock
$0,80
Fiyat · Ağu 19, 2026
Temel veriler itibarıyla Ağu 12, 2026
52 Haftlık Aralık
$1–$3
5% of range
Analist Derecelendirmesi
BUY
13 analysts
Fiyat Hedefi
$6
+650% upside
P/E (TTM)
-1.0
ROE
-86.6%
Net Kâr Marjı
-1256.8%
TCRX Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$0.80
Piyasa Değeri
—
P/E (TTM)
-1.0
EPS (TTM)
$-1.00
Gelir (TTM)
$10M
Temettü Verimi
—
ROE
-86.6%
D/E Borç/Özsermaye
0.3
52 Haftlık Aralık
$1 – $3
TCRX Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Configure
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir ve Net Gelir
$10M
2020-12-31
→
2025-12-31
Hisse Başına Kâr
$-1.00
2021-12-31
→
2025-12-31
Serbest Nakit Akışı
$-140M
2021-12-31
→
2025-12-31
Marjlar
-1256.8%
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Metrik
5 Yıllık trend
TCRX
Akran Ortalaması
P/E (TTM)
-1.0
—
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
TCRX
Akran Ortalaması
Operating Margin (Faaliyet Kâr Marjı)
-1315.4%
—
Net Profit Margin (Net Kâr Marjı)
-1256.8%
-1056.6%
ROA
-43.3%
-68.6%
ROE
-86.6%
-99.6%
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
TCRX
Akran Ortalaması
Debt / Equity (Borç / Öz Sermaye)
0.3
—
Current Ratio (Cari Oran)
8.4
3.7
Quick Ratio (Cari Oran)
8.2
—
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
TCRX
Akran Ortalaması
Revenue YoY (Gelir Yıllık Bazda)
266.7%
—
Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı)
-8.6%
—
Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı)
56.9%
—
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
TCRX
Akran Ortalaması
TCRX Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
AL
13 analist
- Güçlü Al 3 23,1%
- Al 7 53,8%
- Tut 3 23,1%
- Sat 0 0,0%
- Güçlü Sat 0 0,0%
12 Aylık Fiyat Hedefi
4 analist · 2026-08-14
Medyan
$6.00
← Tüm hedeflerin altında
$0.80
Düşük
$5.00
Yüksek
$7.00
Medyan hedef
$6.00
+649,5%
Ortalama hedef
$6.00
+649,5%
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
0.02%
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 31 Mart 2026 | $-0.22 | $-0.18 | -0.04% |
| 31 Aralık 2025 | $-0.18 | $-0.25 | 0.07% |
| 30 Eylül 2025 | $-0.28 | $-0.30 | 0.02% |
| 30 Haziran 2025 | $-0.28 | $-0.29 | 0.01% |
| 31 Mart 2025 | $-0.26 | $-0.29 | 0.03% |
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| TCRX | — | -1.0 | 266.7% | -1256.8% | -86.6% | — |
| RNXT | — | -2.6 | 2511.6% | — | — | — |
| XLO | $3M | -0.2 | 589.9% | -80.0% | -165.5% | — |
| APLM | — | — | — | — | — | — |
| ATYR | $77M | -1.0 | -19.1% | -39009.5% | -107.8% | — |
| TIL | $75M | -1.0 | — | — | -58.1% | — |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 14
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $10M | $3M | $21M | $14M | $10M | $1M | |
| R&D Expense | $114M | $107M | $88M | $60M | $45M | $21M | |
| SG&A Expense | $32M | $30M | $26M | $20M | $14M | $7M | |
| Operating Expenses | $146M | $138M | $115M | $80M | $59M | $27M | |
| Operating Income | $-136M | $-135M | $-93M | $-67M | $-49M | $-26M | |
| Interest Expense | $3M | $4M | $4M | $1M | · | · | |
| Other Non-op | $6M | $7M | $4M | $415.0K | $16.0K | · | |
| Income Tax | $0 | · | · | · | · | · | |
| Net Income | $-130M | $-127M | $-89M | $-66M | $-49M | $-26M | |
| EPS (Basic) | $-1.00 | $-1.14 | $-1.36 | $-2.75 | $-4.17 | · | |
| EPS (Diluted) | $-1.00 | $-1.14 | $-1.36 | $-2.75 | $-4.17 | · | |
| Shares (Basic) | 129,777,415 | 111,990,417 | 65,599,858 | 24,048,267 | 11,662,672 | · | |
| Shares (Diluted) | 129,777,415 | 111,990,417 | 65,599,858 | 24,048,267 | 11,662,672 | · | |
| EBITDA | $-136M | $-135M | · | $-67M | $-49M | · |
Bilanço 21
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $152M | $179M | $133M | $120M | $161M | $35M | |
| Short-term Investments | · | $111M | $59M | · | · | · | |
| Prepaid Expense | $5M | $3M | $2M | $4M | $4M | $2M | |
| Current Assets | $157M | $293M | $194M | $124M | $166M | $36M | |
| PP&E (Net) | $9M | $7M | $8M | $10M | $12M | $6M | |
| PP&E (Gross) | $30M | $26M | $22M | $20M | $17M | $7M | |
| Accum. Depreciation | $22M | $19M | $15M | $10M | $5M | $2M | |
| Total Assets | $229M | $371M | $272M | $199M | $188M | $50M | |
| Accounts Payable | $1M | $4M | $2M | $3M | $2M | $3M | |
| Current Liabilities | $19M | $36M | $30M | $17M | $21M | $17M | |
| Capital Leases | $54M | $61M | $59M | $53M | $4M | $6M | |
| Other Non-current Liabilities | · | $135.0K | · | $49.0K | $97.0K | $238.0K | |
| Total Liabilities | $106M | $130M | $121M | $100M | $27M | $33M | |
| Long-term Debt | $33M | $32M | $30M | $29M | · | · | |
| Total Debt | $33M | $32M | · | $29M | · | · | |
| Common Stock | · | · | · | · | · | $1.0K | |
| Retained Earnings | $-505M | $-375M | $-248M | $-158M | $-92M | $-44M | |
| AOCI | · | $51.0K | · | · | · | · | |
| Stockholders' Equity | $123M | $241M | $151M | $99M | $161M | $-42M | |
| Liabilities + Equity | $229M | $371M | $272M | $199M | $188M | $50M | |
| Shares Outstanding | 52,625,035 | 52,314,039 | · | 19,082,820 | 18,764,463 | 1,135,858 |
Nakit Akışı 12
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $3M | $4M | $5M | $5M | $3M | $1M | |
| Stock-based Comp | $12M | $10M | $5M | $5M | $3M | $515.0K | |
| Operating Cash Flow | $-135M | $-111M | $-61M | $-67M | $-49M | $-3M | |
| CapEx | $4M | $4M | $3M | $4M | $10M | $4M | |
| Investing Cash Flow | $109M | $-53M | $-61M | $-4M | $-10M | $-4M | |
| Debt Issued | · | · | · | $29M | · | · | |
| Net Debt Issued | · | · | · | $29M | · | · | |
| Stock Issued | · | $33M | $42M | $193.0K | · | · | |
| Net Stock Activity | · | $33M | · | $193.0K | · | · | |
| Financing Cash Flow | $-336.0K | $209M | $135M | $29M | $190M | $288.0K | |
| Net Change in Cash | $-26M | $45M | $13M | $-41M | $131M | $-7M | |
| Free Cash Flow | $-140M | $-115M | · | $-71M | $-59M | · |
Kârlılık 5
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -1315.4% | -4787.7% | · | -492.3% | -479.6% | · | |
| Net Margin | -1256.8% | -4527.7% | · | -489.3% | -479.5% | · | |
| EBITDA Margin | -1315.4% | -4787.7% | · | -492.3% | -479.6% | · | |
| ROA | -43.3% | -39.6% | · | -34.2% | -40.9% | · | |
| ROE | -86.6% | -54.2% | · | -61.3% | -29.0% | · |
Likidite ve Solventlik 5
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 8.4 | 8.1 | · | 7.2 | 7.8 | · | |
| Quick Ratio | 8.2 | 8.1 | · | 6.9 | 7.6 | · | |
| Debt / Equity | 0.3 | 0.1 | · | 0.3 | · | · | |
| LT Debt / Equity | 0.3 | 0.1 | · | 0.3 | · | · | |
| Interest Coverage | -49.0 | -36.9 | · | -56.7 | · | · |
Verimlilik 1
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.1 | 0.1 | · |
Büyüme Oranları 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | 266.7% | -86.6% | 55.5% | 33.5% | 834.7% | · | |
| Revenue CAGR 3Y | -8.6% | -34.8% | 168.7% | · | · | · | |
| Revenue CAGR 5Y | 56.9% | · | · | · | · | · |
Değerleme (TTM) 4
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $10M | $3M | $21M | $14M | $10M | · | |
| Net Income TTM | $-130M | $-127M | $-89M | $-66M | $-49M | · | |
| P/E | -1.0 | -2.7 | -4.3 | -0.6 | -1.1 | · | |
| Earnings Yield | -100.0% | -37.5% | -23.3% | -177.4% | -92.7% | · |
Gelir Tablosu 13
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1M | $982.0K | $3M | $3M | $3M | $2M | $665.0K | $1M | $536.0K | $566.0K | $7M | $4M | $3M | $7M | $3M | $3M | |
| R&D Expense | $23M | $22M | $20M | $32M | $33M | $30M | $29M | $26M | $27M | $25M | $22M | $23M | $21M | $22M | $16M | $15M | |
| SG&A Expense | $8M | $8M | $6M | $8M | $9M | $9M | $8M | $7M | $8M | $7M | $6M | $6M | $7M | $8M | $6M | $5M | |
| Operating Expenses | $32M | $30M | $26M | $40M | $42M | $38M | $37M | $34M | $35M | $32M | $29M | $29M | $28M | $30M | $22M | $20M | |
| Operating Income | $-30M | $-29M | $-24M | $-37M | $-39M | $-36M | $-37M | $-33M | $-34M | $-31M | $-21M | $-25M | $-25M | $-23M | $-19M | $-17M | |
| Interest Expense | $699.0K | $689.0K | $702.0K | $699.0K | $689.0K | $679.0K | $784.0K | $958.0K | $952.0K | $959.0K | $852.0K | $982.0K | $969.0K | $956.0K | $975.0K | $201.0K | |
| Other Non-op | $134.0K | $473.0K | $881.0K | $1M | $2M | $2M | $903.0K | $3M | $2M | $1M | $2M | $2M | $565.0K | $180.0K | $-74.0K | $333.0K | |
| Net Income | $-30M | $-29M | $-23M | $-36M | $-37M | $-34M | $-36M | $-30M | $-32M | $-30M | $-20M | $-23M | $-24M | $-23M | $-19M | $-16M | |
| EPS (Basic) | $-0.23 | $-0.22 | $-0.18 | $-0.28 | $-0.28 | $-0.26 | $-0.29 | $-0.25 | $-0.28 | $-0.32 | $0.32 | $-0.24 | $-0.51 | $-0.93 | $-0.78 | $-0.67 | |
| EPS (Diluted) | $-0.23 | $-0.22 | $-0.18 | $-0.28 | $-0.28 | $-0.26 | $-0.29 | $-0.25 | $-0.28 | $-0.32 | $0.32 | $-0.24 | $-0.51 | $-0.93 | $-0.78 | $-0.67 | |
| Shares (Basic) | 129,948,878 | 129,913,376 | -259,467,546 | 129,835,938 | 129,730,451 | 129,678,572 | -215,011,195 | 118,700,362 | 113,425,357 | 94,875,893 | -100,664,604 | 94,829,844 | 47,208,664 | 24,225,954 | -48,063,987 | 24,073,935 | |
| Shares (Diluted) | 129,948,878 | 129,913,376 | -259,467,546 | 129,835,938 | 129,730,451 | 129,678,572 | -215,011,195 | 118,700,362 | 113,425,357 | 94,875,893 | -100,664,604 | 94,829,844 | 47,208,664 | 24,225,954 | -48,063,987 | 24,073,935 | |
| EBITDA | $-30M | $-29M | · | $-37M | $-39M | $-36M | · | $-33M | $-34M | $-31M | · | $-25M | $-25M | $-23M | · | $-17M |
Bilanço 21
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $100M | $128M | $152M | $170M | $169M | $154M | $179M | $133M | $242M | $141M | $133M | $155M | $209M | $96M | $120M | $137M | |
| Short-term Investments | · | · | · | $15M | $49M | $98M | $111M | $138M | $56M | $22M | $59M | $60M | · | · | · | · | |
| Receivables | · | · | · | · | · | · | · | · | · | · | · | · | $32M | · | · | · | |
| Prepaid Expense | $4M | $5M | $5M | $4M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $1M | $5M | $4M | $4M | |
| Current Assets | $104M | $133M | $157M | $188M | $221M | $255M | $293M | $274M | $300M | $165M | $194M | $218M | $242M | $101M | $124M | $141M | |
| PP&E (Net) | $8M | $8M | $9M | $9M | $10M | $8M | $7M | $7M | $8M | $7M | $8M | $9M | $8M | $9M | $10M | $10M | |
| PP&E (Gross) | · | · | $30M | · | · | · | $26M | · | · | · | $22M | · | · | · | $20M | · | |
| Accum. Depreciation | · | · | $22M | · | · | · | $19M | · | · | · | $15M | · | · | · | $10M | · | |
| Total Assets | $171M | $202M | $229M | $262M | $299M | $333M | $371M | $348M | $375M | $241M | $272M | $291M | $317M | $174M | $199M | $165M | |
| Accounts Payable | $3M | $2M | $1M | $6M | $5M | $5M | $4M | $4M | $3M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | |
| Current Liabilities | $31M | $20M | $19M | $29M | $31M | $30M | $36M | $29M | $39M | $31M | $30M | $33M | $35M | $14M | $17M | $17M | |
| Capital Leases | $50M | $52M | $54M | $56M | $58M | $60M | $61M | $56M | $57M | $58M | $59M | $53M | $54M | $52M | $53M | $3M | |
| Other Non-current Liabilities | · | · | · | $278.0K | $113.0K | $124.0K | $135.0K | $146.0K | · | · | · | $12.0K | $24.0K | $36.0K | $49.0K | $97.0K | |
| Total Liabilities | $102M | $105M | $106M | $118M | $122M | $123M | $130M | $119M | $120M | $118M | $121M | $122M | $126M | $96M | $100M | $49M | |
| Long-term Debt | $33M | $33M | $33M | $32M | $32M | $32M | · | $31M | $30M | $30M | $30M | $30M | $30M | $30M | · | $29M | |
| Total Debt | $33M | $33M | · | $32M | $32M | $32M | · | $31M | $30M | $30M | · | $30M | $30M | $30M | · | $29M | |
| Retained Earnings | $-564M | $-534M | $-505M | $-482M | $-446M | $-409M | $-375M | $-339M | $-309M | $-278M | $-248M | $-228M | $-205M | $-181M | $-158M | $-140M | |
| AOCI | · | · | · | $2.0K | $-4.0K | $-4.0K | $51.0K | · | · | · | · | · | · | · | · | · | |
| Stockholders' Equity | $69M | $97M | $123M | $144M | $177M | $210M | $241M | $229M | $255M | $123M | $151M | $169M | $191M | $78M | $99M | $117M | |
| Liabilities + Equity | $171M | $202M | $229M | $262M | $299M | $333M | $371M | $348M | $375M | $241M | $272M | $291M | $317M | $174M | $199M | $165M | |
| Shares Outstanding | 63,502,667 | 55,824,722 | · | · | · | · | · | · | · | · | · | 43,546,528 | 43,542,178 | 19,480,729 | · | · |
Nakit Akışı 9
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | |
| Operating Cash Flow | $-28M | $-24M | $-32M | $-32M | $-33M | $-38M | $-27M | $-28M | $-26M | $-29M | $-24M | $8M | $-22M | $-24M | $-16M | $-17M | |
| CapEx | $493.0K | $70.0K | $171.0K | $1M | $1M | $2M | $888.0K | $1M | $862.0K | $705.0K | $469.0K | $1M | $420.0K | $838.0K | $1M | $424.0K | |
| Investing Cash Flow | $-465.0K | $-70.0K | $15M | $33M | $48M | $14M | $27M | $-82M | $-34M | $36M | $2M | $-61M | $-420.0K | $-838.0K | $-1M | $-424.0K | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | |
| Stock Issued | · | · | · | · | · | · | $0 | $0 | · | · | $0 | $-186.0K | · | · | · | · | |
| Financing Cash Flow | · | · | $73.0K | $0 | $116.0K | $-525.0K | $46M | $1M | $162M | $258.0K | $19.0K | $-252.0K | · | · | $108.0K | $29M | |
| Net Change in Cash | $-28M | $-24M | $-17M | $112.0K | $15M | $-25M | $46M | $-109M | $102M | $7M | $-22M | $-54M | $113M | $-24M | $-17M | $12M | |
| Free Cash Flow | · | $-24M | · | · | · | $-39M | · | · | · | $-30M | · | · | · | $-24M | · | · |
Kârlılık 5
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -2901.3% | -2967.3% | · | -1475.6% | -1256.6% | -1669.7% | · | -3109.8% | -6364.6% | -5542.9% | · | -636.7% | -781.8% | -334.3% | · | -492.9% | |
| Net Margin | -2888.6% | -2919.1% | · | -1422.1% | -1201.3% | -1572.0% | · | -2849.1% | -5906.9% | -5325.4% | · | -591.6% | -763.8% | -331.7% | · | -483.0% | |
| EBITDA Margin | -2901.3% | -2967.3% | · | -1475.6% | -1256.6% | -1669.7% | · | -3109.8% | -6364.6% | -5542.9% | · | -636.7% | -781.8% | -334.3% | · | -492.9% | |
| ROA | -12.9% | -10.7% | · | -11.7% | -11.0% | -11.9% | · | -9.3% | -9.2% | -14.5% | · | -10.1% | -10.2% | -13.2% | · | -8.8% | |
| ROE | -24.7% | -18.7% | · | -19.1% | -17.1% | -20.5% | · | -15.0% | -14.2% | -30.0% | · | -16.1% | -14.9% | -20.2% | · | -11.2% |
Likidite ve Solventlik 5
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.4 | 6.6 | · | 6.4 | 7.1 | 8.5 | · | 9.6 | 7.8 | 5.2 | · | 6.6 | 6.9 | 7.2 | · | 8.5 | |
| Quick Ratio | 3.2 | 6.4 | · | 6.3 | 7.0 | 8.4 | · | 9.5 | 7.7 | 5.2 | · | 6.5 | 6.9 | 6.8 | · | 8.3 | |
| Debt / Equity | 0.5 | 0.3 | · | 0.2 | 0.2 | 0.2 | · | 0.1 | 0.1 | 0.2 | · | 0.2 | 0.2 | 0.4 | · | 0.2 | |
| LT Debt / Equity | 0.3 | 0.3 | · | 0.2 | 0.2 | 0.2 | · | 0.1 | 0.1 | 0.2 | · | 0.2 | 0.2 | 0.4 | · | 0.2 | |
| Interest Coverage | -43.6 | -42.3 | · | -53.0 | -56.1 | -53.4 | · | -34.1 | -35.8 | -32.7 | · | -25.2 | -25.4 | -23.8 | · | -82.5 |
Verimlilik 2
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | · | · | · | · | · | · | · | · | · | · | · | · | 0.2 | · | · | · |
Değerleme (TTM) 14
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $8M | $9M | · | $9M | $7M | $4M | · | $6M | $8M | $14M | · | $17M | $17M | $17M | · | $13M | |
| Net Income TTM | $-132M | $-135M | · | $-137M | $-133M | $-126M | · | $-115M | $-109M | $-100M | · | $-86M | $-78M | $-70M | · | $-63M | |
| Market Cap | $62M | $56M | · | · | · | · | · | · | · | · | · | $111M | $109M | $41M | · | · | |
| Enterprise Value | $-5M | $-39M | · | · | · | · | · | · | · | · | · | $-74M | $-70M | $-25M | · | · | |
| P/E | -1.0 | -1.0 | · | -1.7 | -1.4 | -1.2 | · | -4.6 | -4.3 | -4.0 | · | -1.1 | -0.9 | -0.7 | · | -1.1 | |
| P/S | 8.2 | 6.5 | · | · | · | · | · | · | · | · | · | 6.5 | 6.3 | 2.4 | · | · | |
| P/B | 0.9 | 0.6 | · | · | · | · | · | · | · | · | · | 0.7 | 0.6 | 0.5 | · | · | |
| P / Tangible Book | 0.9 | 0.6 | · | · | · | · | · | · | · | · | · | 0.7 | 0.6 | 0.5 | · | · | |
| P / Cash Flow | · | -2.3 | · | · | · | · | · | · | · | · | · | · | · | -1.7 | · | · | |
| P / FCF | · | -2.3 | · | · | · | · | · | · | · | · | · | · | · | -1.7 | · | · | |
| EV / EBITDA | 0.2 | 1.3 | · | · | · | · | · | · | · | · | · | 3.0 | 2.9 | 1.1 | · | · | |
| EV / FCF | · | 1.6 | · | · | · | · | · | · | · | · | · | · | · | 1.0 | · | · | |
| EV / Revenue | -0.7 | -4.5 | · | · | · | · | · | · | · | · | · | -4.3 | -4.0 | -1.5 | · | · | |
| Earnings Yield | -103.1% | -103.0% | · | -58.8% | -73.8% | -80.4% | · | -21.9% | -23.1% | -25.2% | · | -91.8% | -109.6% | -138.1% | · | -90.8% |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Gelir | $10M | $3M | $21M | $14M | $10M |
| Faaliyet Kâr Marjı % | -1315.4% | -4787.7% | — | -492.3% | -479.6% |
| Net Gelir | $-130M | $-127M | $-89M | $-66M | $-49M |
| Seyreltilmiş Hisse Başı Kâr | $-1.00 | $-1.14 | $-1.36 | $-2.75 | $-4.17 |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | 0.3 | 0.1 | — | 0.3 | — |
| Cari Oran | 8.4 | 8.1 | — | 7.2 | 7.8 |
| Cari Oran | 8.2 | 8.1 | — | 6.9 | 7.6 |
Nakit Akışı
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-140M | $-115M | — | $-71M | $-59M |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kurumsal Sahipler (13F) 65 dosya · $31.2M toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 11 (+4 önceki Ç'ye göre) | 7 (-3 önceki Ç'ye göre) | 18 (+2 önceki Ç'ye göre) | 12 (-7 önceki Ç'ye göre) | +5.9M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| Lynx1 Capital Management LP | $7.859.567 | 8.019.148 | 25,20% | Hisse senetleri |
| BVF INC/IL | $5.453.561 | 5.564.290 | 17,49% | Hisse senetleri |
| BAKER BROS. ADVISORS LP | $2.729.375 | 2.784.792 | 8,75% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $2.115.654 | 2.158.831 | 6,78% | Hisse senetleri |
| TWO SIGMA INVESTMENTS, LP | $1.910.807 | 1.949.604 | 6,13% | Hisse senetleri |
| RENAISSANCE TECHNOLOGIES LLC | $1.300.396 | 1.326.799 | 4,17% | Hisse senetleri |
| Deer Management Co. LLC | $1.220.594 | 1.245.504 | 3,91% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $1.140.455 | 1.163.611 | 3,66% | Hisse senetleri |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $1.028.915 | 1.049.806 | 3,30% | Hisse senetleri |
| BOOTHBAY FUND MANAGEMENT, LLC | $756.873 | 772.241 | 2,43% | Hisse senetleri |
| MARSHALL WACE, LLP | $673.616 | 687.364 | 2,16% | Hisse senetleri |
| DC Funds, LP | $617.463 | 630.000 | 1,98% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $466.526 | 475.766 | 1,50% | Hisse senetleri |
| Kalehua Capital Management LLC | $445.824 | 454.876 | 1,43% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $356.675 | 363.954 | 1,14% | Hisse senetleri |
| D. E. Shaw & Co., Inc. | $356.234 | 363.467 | 1,14% | Hisse senetleri |
| TWO SIGMA ADVISERS, LP | $353.900 | 353.900 | 1,13% | Hisse senetleri |
| Verdad Advisers, LP | $228.127 | 232.759 | 0,73% | Hisse senetleri |
| JANE STREET GROUP, LLC | $206.372 | 210.562 | 0,66% | Hisse senetleri |
| STATE STREET CORP | $203.187 | 207.313 | 0,65% | Hisse senetleri |
| MIZUHO SECURITIES USA LLC | $201.509 | 205.600 | 0,65% | Hisse senetleri |
| XTX Topco Ltd | $146.493 | 149.467 | 0,47% | Hisse senetleri |
| BROWN BROTHERS HARRIMAN & CO | $140.204 | 143.051 | 0,45% | Hisse senetleri |
| NORTHERN TRUST CORP | $136.016 | 138.778 | 0,44% | Hisse senetleri |
| LETKO, BROSSEAU & ASSOCIATES INC | $93.967 | 95.875 | 0,30% | Hisse senetleri |
| NewEdge Wealth, LLC | $89.643 | 91.463 | 0,29% | Hisse senetleri |
| Cubist Systematic Strategies, LLC | $76.582 | 42.078 | 0,25% | Hisse senetleri |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $75.370 | 76.900 | 0,24% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $69.111 | 70.514 | 0,22% | Hisse senetleri |
| AMERIPRISE FINANCIAL INC | $68.104 | 69.487 | 0,22% | Hisse senetleri |
| STIFEL FINANCIAL CORP | $66.838 | 68.200 | 0,21% | Hisse senetleri |
| Kestra Advisory Services, LLC | $61.281 | 62.525 | 0,20% | Hisse senetleri |
| Nuveen Asset Management, LLC | $54.589 | 17.957 | 0,18% | Hisse senetleri |
| UBS Group AG | $54.178 | 55.284 | 0,17% | Hisse senetleri |
| MORGAN STANLEY | $41.110 | 41.945 | 0,13% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $36.832 | 37.584 | 0,12% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $36.551 | 37.293 | 0,12% | Hisse senetleri |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | $35.872 | 36.600 | 0,12% | Hisse senetleri |
| DC Investments Management, LLC | $34.855 | 35.563 | 0,11% | Hisse senetleri |
| Point72 Asia (Singapore) Pte. Ltd. | $26.454 | 14.535 | 0,08% | Hisse senetleri |
| CITADEL ADVISORS LLC | $25.826 | 26.350 | 0,08% | Hisse senetleri |
| HSBC HOLDINGS PLC | $23.842 | 24.574 | 0,08% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $23.153 | 23.623 | 0,07% | Hisse senetleri |
| R Squared Ltd | $17.995 | 18.360 | 0,06% | Hisse senetleri |
| Vanguard Personalized Indexing Management, LLC | $17.602 | 17.959 | 0,06% | Hisse senetleri |
| BARCLAYS PLC | $16.740 | 17.080 | 0,05% | Hisse senetleri |
| VANGUARD GROUP INC | $15.705 | 15.705 | 0,05% | Hisse senetleri |
| Vanguard Global Advisers, LLC | $15.391 | 15.705 | 0,05% | Hisse senetleri |
| OSAIC HOLDINGS, INC. | $11.999 | 12.245 | 0,04% | Hisse senetleri |
| BlackRock, Inc. | $11.026 | 11.250 | 0,04% | Hisse senetleri |
| Aries Wealth Management | $9.801 | 10.000 | 0,03% | Hisse senetleri |
| Global Retirement Partners, LLC | $9.801 | 10.000 | 0,03% | Hisse senetleri |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | $7.373 | 7.523 | 0,02% | Hisse senetleri |
| FEDERATED HERMES, INC. | $3.903 | 3.982 | 0,01% | Hisse senetleri |
| Tower Research Capital LLC (TRC) | $2.498 | 2.549 | 0,01% | Hisse senetleri |
| FMR LLC | $1.372 | 1.400 | 0,00% | Hisse senetleri |
| ACADIAN ASSET MANAGEMENT LLC | $1.276 | 1.305.840 | 0,00% | Hisse senetleri |
| JPMORGAN CHASE & CO | $1.151 | 1.177 | 0,00% | Hisse senetleri |
| BNP PARIBAS FINANCIAL MARKETS | $699 | 713 | 0,00% | Hisse senetleri |
| GSA CAPITAL PARTNERS LLP | $537 | 548.087 | 0,00% | Hisse senetleri |
| SBI Securities Co., Ltd. | $384 | 392 | 0,00% | Hisse senetleri |
| Strategic Wealth Partners, Ltd. | $305 | 311 | 0,00% | Hisse senetleri |
| HRT FINANCIAL LP | $161 | 164.601 | 0,00% | Hisse senetleri |
| Caitong International Asset Management Co., Ltd | $1 | 1 | 0,00% | Hisse senetleri |
| ROYAL BANK OF CANADA | $0 | 78 | 0,00% | Hisse senetleri |
Şirket yöneticileri 17 içeriden öğrenenler · 9 yöneticiler · 9 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Gavin Macbeath | Chief Executive Officer | 20 Ocak 2026 A | 49.767 | 0 | 0 | $0 |
| David P Southwell | Chief Executive Officer | 02 Şubat 2023 A | 171.569 | 0 | 0 | $0 |
| Jason Amello | Chief Financial Officer | 20 Ocak 2026 A | — | 0 | 0 | $0 |
| Brian M. Silver | Chief Financial Officer | 13 Haziran 2023 A | 32.885 | 0 | 0 | $0 |
| Chrystal Louis | Chief Medical Officer | 20 Ocak 2026 A | — | 0 | 0 | $0 |
| Leiden Dworak | Principal Accounting Officer and Vice President, Finance | 20 Ocak 2026 A | — | 0 | 0 | $0 |
| Zoran Zdraveski | Exhibit List - Exhibit 24 - Power of Attorney; Chief Legal and Strategy Officer | 20 Ocak 2026 A | 4.716 | 0 | 0 | $0 |
| Debora Barton | Chief Medical Officer | 13 Haziran 2023 A | — | 0 | 0 | $0 |
| William Desmarais | Chief Business Officer | 25 Temmuz 2022 A | 2.500 | 0 | 0 | $0 |
| Keith Woods | Yönetim kurulu üyesi | 20 Mayıs 2026 A | — | 0 | 0 | $0 |
| Gabriela Gruia | Yönetim kurulu üyesi | 20 Mayıs 2026 A | — | 0 | 0 | $0 |
| Barbara Klencke | Yönetim kurulu üyesi | 20 Mayıs 2026 A | 45.000 | 0 | 0 | $0 |
| Garry A Nicholson | Yönetim kurulu üyesi | 20 Mayıs 2026 A | — | 0 | 0 | $0 |
| Katina Dorton | Yönetim kurulu üyesi | 20 Mayıs 2026 A | — | 0 | 0 | $0 |
| BARBERICH TIMOTHY J | Yönetim kurulu üyesi | 19 Aralık 2023 P | 67.027 | 0 | 0 | $0 |
| Ittai Harel | Yönetim kurulu üyesi | 01 Haziran 2022 A | — | 0 | 0 | $0 |
| Christoph H Westphal | 10% sahip | 20 Temmuz 2021 C | 1.278.838 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
Aktivistler ve %5+ sahipler 1 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Baker Bros. Advisors LP, Baker Bros. Advisors (GP) LLC, Felix J. Baker, Julian C. Baker ×4 başvurular | 23 Nisan 2024 | — | İlk başvuru | Sermaye yapısı | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF sahipliği 3 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.